---
title: "CNTB.US (CNTB.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CNTB.US/news.md"
symbol: "CNTB.US"
name: "CNTB.US"
parent: "https://longbridge.com/en/quote/CNTB.US.md"
datetime: "2026-05-20T17:06:29.387Z"
locales:
  - [en](https://longbridge.com/en/quote/CNTB.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CNTB.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CNTB.US/news.md)
---

# CNTB.US (CNTB.US) — Related News

### [Connect Biopharma Holdings (CNTB) Gets a Buy from H.C. Wainwright](https://longbridge.com/en/news/286133673.md)
*2026-05-12T16:36:18.000Z*
> H.C. Wainwright analyst Brandon Folkes has reiterated a Buy rating on Connect Biopharma Holdings (CNTB) with a price tar

### [Connect Biopharma | 8-K: FY2026 Q1 Revenue: USD 169 K](https://longbridge.com/en/news/286106226.md)
*2026-05-12T13:09:15.000Z*
### [Northland Securities Remains a Buy on Connect Biopharma Holdings (CNTB)](https://longbridge.com/en/news/284010826.md)
*2026-04-24T13:15:53.000Z*
> Northland Securities analyst Carl Byrnes has maintained a Buy rating on Connect Biopharma Holdings (CNTB) with a price t

### [Connect Biopharma | 10-K: FY2025 Revenue: USD 64 K](https://longbridge.com/en/news/283991477.md)
*2026-04-24T11:28:20.000Z*
### [Connect Biopharma Advances Enrolment In Phase 2 Seabreeze STAT Trial For Asthma Drug Rademikibart](https://longbridge.com/en/news/283976564.md)
*2026-04-24T10:00:59.000Z*
> Connect Biopharma Holdings Ltd. (CNTB) has announced the advancement of enrolment in the Phase 2 Seabreeze STAT trial fo

### [Connect Biopharma Advances Rademikibart After Positive Interim Review](https://longbridge.com/en/news/283846604.md)
*2026-04-23T13:30:22.000Z*
> Connect Biopharma Holdings (CNTB) announced that an independent Data Monitoring Committee completed a positive interim e

### [Top 5 CDRs Gainers/Losers (>100M) (4.20)](https://longbridge.com/en/news/283406390.md)
*2026-04-20T22:01:01.000Z*
> Cango(CANG) rose 29.73%, with a trading turnover 8.6 Million USD, and a year-to-date fell 68%. ECARX(ECX) rose 8.4%, wit

### [Top 5 CDRs Gainers/Losers (>100M) (4.17)](https://longbridge.com/en/news/283199134.md)
*2026-04-17T22:00:51.000Z*
> Intchains(ICG) rose 25.84%, with a trading turnover 27.2 Million USD, and a year-to-date fell 6.1%. Zepp Health(ZEPP) ro